Concepedia

Elizabeth R. Duke

ER

Statistics

Publications

28

Citations

1.7K

H-Index

20

Active since

2007

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

University of North Carolina at Chapel Hill

Merck & Co., Inc., Rahway, NJ, USA (United States)

Infectious Disease Research Institute

Elizabeth R. Duke is an author at Fred Hutch Cancer Center specializing in infectious diseases, life sciences, and immunology.

ORCID

Publications per year

2007–2024

28

Publications

28

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · Science Translational Medicine · 2021 · 361 citations · Full text

, , +17

Molnupiravir, an Oral Antiviral Treatment for COVID-19

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · medRxiv · 2021 · 218 citations · Full text

, , +16

Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation

Danniel Zamora, Elizabeth R. Duke, Hu Xie et al. · Blood · 2021 · 161 citations · Full text

, , +16

A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation

Daniel B. Reeves, Elizabeth R. Duke, Thor A. Wagner et al. · Nature Communications · 2018 · 151 citations · Full text

, , +17

Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19

Matthew G. Johnson, Amy Puenpatom, Pablo Andrés Moncada et al. · Annals of Internal Medicine · 2022 · 71 citations · Full text

, , +11

1–5 of 28